Postoperative Radiotherapy in Stage I-III Merkel Cell Carcinoma

CONCLUSIONS: PORT was associated with less recurrences and improved OS in patients with stage I-III MCC, but not with improved MCC-related survival. Trends in OS benefit are likely to be caused by selection bias suggesting further refinement of criteria for PORT is warranted, for instance by taking life expectancy into account.PMID:34838887 | DOI:10.1016/j.radonc.2021.11.017

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - November 28, 2021 Category: Radiology Authors: Sonja Levy Stephanie A Blankenstein Dirk Jan Gr ünhagen Mathilde Jalving Olga Hamming-Vrieze Lukas B Been Lisa Tans Alexander C J van Akkooi Margot E T Tesselaar Source Type: research